Status:
TERMINATED
Dietary Supplements for COVID-19
Lead Sponsor:
The Canadian College of Naturopathic Medicine
Collaborating Sponsors:
Ottawa Hospital Research Institute
Vitazan Professional
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a double blind, placebo controlled, phase III randomized controlled trial evaluating the effects of the dietary supplements vitamin C, vitamin D, vitamin K, and zinc versus placebo on the over...
Detailed Description
This study proposed is a double-blind, placebo-controlled, phase III randomized controlled trial powered to detect meaningful differences in the overall health and symptom severity of people with COVI...
Eligibility Criteria
Inclusion
- Adults (≥18) who test positive for SARS-CoV-2 in an outpatient setting
- Access to internet
Exclusion
- Symptom onset greater than 4 days prior to enrolment
- Supplementing regularly with \>500 mg vitamin C, \>1000 units vitamin D, \>120 mcg vitamin K (any form), or \>15 mg zinc taken daily within the past month
- Currently taking warfarin or an equivalent vitamin K antagonist anticoagulant
- End stage chronic kidney disease
- History of calcium oxalate kidney stones
- Active granulomatosis (sarcoidosis, tuberculosis, lymphoma)
- Known hypercalcemia or hypervitaminosis D
- Currently taking either of the following antibiotics: cephalexin, tetracyclines
- Participating in an investigational study or participation in an investigational study within the past 30 days
- Any reason which, under the discretion of the qualified investigator or delegate, would preclude the patient from participating.
Key Trial Info
Start Date :
July 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04780061
Start Date
July 12 2021
End Date
July 7 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Centre for Health Innovation
Ottawa, Ontario, Canada, K2P0M7